Inventor · disambiguated record
Pandiaraju Subramanian
Also filed as: SUBRAMANIAN PANDIARAJU
5 granted patents·2 pending applications·7 citations·filing 2017–2022
68Inventor score
Top patents by PatentIndex Score
7 records- 0180US11518764B2Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interactionONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2019·Granted Dec 6, 2022·3 cites·18 claims
- 0279US11174250B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2017·Granted Nov 16, 2021·3 cites·23 claims
- 0368US11319299B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2017·Granted May 3, 2022·1 cites·39 claims
- 0461US12264147B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2022·Granted Apr 1, 2025·0 cites·2 claims
- 0556US2024343704A1Halo-substituted amino pyridine compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 0645US2020385371A1Inhibitors of wdr5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0742US11242351B2Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2018·Granted Feb 8, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Pandiaraju Subramanian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →